Influenza Testing - Impact of New Testing and New Testing Options

 

Influenza Testing — Impact of New Testing and New Testing Options

Glen T. Hansen, PhD, FCCM, D(ABMM), Ann Cox, MT (ASCP) and Kendra Schmidt, BS, MT(ASCP) discuss the epidemiology of influenza and the clinical challenges of assessing actual influenza patients. The trio of presenters also examine the contemporary challenges with applying molecular testing outside of the centralized laboratory, discuss the advantages and limitations of current testing options, review how rapid influenza test results can be applied to patient care, and describe the implementation and outcomes of applying rapid PCR to ancillary locations.

 

No Previous Articles

Next Article
Automating Anatomic Pathology
Automating Anatomic Pathology

J. Mark Tuthill, MD, Division of Pathology Informatics, Henry Ford Hospital, presents the experiences at He...

×

LabLeaders.com has a new home. Tell us a bit about yourself.

First Name
Last Name
Mobile Phone Number
Thank you!
Error - something went wrong!